tiprankstipranks
Trending News
More News >
Parnell Pharmaceuticals Holdings (PARNF)
OTHER OTC:PARNF
US Market

Parnell Pharmaceuticals (PARNF) Ownership - Who Owns Parnell Pharmaceuticals?

Compare
16 Followers

Parnell Pharmaceuticals (PARNF) Ownership Overview

1.51%98.49%
1.51% Other Institutional Investors
98.49% Public Companies and
Individual Investors
The ownership structure of Parnell Pharmaceuticals (PARNF) stock is a mix of institutional, retail, and individual investors. , and 98.49% is owned by Public Companies and Individual Investors.
The ownership structure of Parnell Pharmaceuticals (PARNF) stock is a mix of institutional, retail, and individual investors. , 1.51% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Parnell Pharmaceuticals Holdings (PARNF)?
Currently, no data Available
What percentage of Parnell Pharmaceuticals Holdings (PARNF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.51% of Parnell Pharmaceuticals Holdings (PARNF) stock is held by institutional investors.
    What percentage of Parnell Pharmaceuticals Holdings (PARNF) stock is held by retail investors?
    According to the latest TipRanks data, approximately 98.49% of Parnell Pharmaceuticals Holdings (PARNF) stock is held by retail investors.
      Who owns the most shares of Parnell Pharmaceuticals Holdings (PARNF)?
      Currently, no data Available
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis